Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials

During this webinar, Charlotte Teunissen, Professor in Neurochemistry at Amsterdam UMC touched upon:

• Patient selection
• Patient stratification
• Outcome measures